A CYP2C19 genotype guided dosing approach for optimizing voriconazole in patients with IFIs.

318.

  • Hamadeh, Issam Pharm.D.
  • Schmidt, S. Ph.D.
  • Mangal, N. Ph.D., Candidate
  • Hiemenz, J. M.D.
  • Langaee, T. Ph.D.
  • Peloquin, C. Pharm.D.
  • Wiggins, L. Pharm.D.
  • Arp, C. Pharm.D.
  • Kinkler, K. Pharm.D.
  • Johnson, J. Pharm.D.

  • Pharmacotherapy and translational Research, University of Florida, Gainesville, FL

Pharmacotherapy: The Journal Of Human Pharmacology & Drug Therapy 34(10):p e261, October 2014.
Copyright © Pharmacotheraphy Publications, Inc. All rights reserved.
View full text|Download PDF